Tubuloglomerular feedback is decreased in COX-1 knockout mice after chronic angiotensin II infusion

American Journal of Physiology - Renal Physiology

Volumn 298, Issue 4, 2010, Pages

  Araujo, Magali ^a   Welch, William J ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

Cyclooxygenase; Hypertension; Prostaglandins

Indexed keywords

6 KETO PROSTAGLANDIN F2 ALPHA; ANGIOTENSIN II; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; PROSTACYCLIN; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; THROMBOXANE B2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEEDBACK SYSTEM; FLUID BALANCE; GLOMERULUS; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY TUBULE; KNOCKOUT MOUSE; MACULA DENSA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN METABOLISM; PROSTAGLANDIN SYNTHESIS; PROSTAGLANDIN URINE LEVEL;

EID: 77950788141     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00547.2009     Document Type: Article

References (26)

1. Araujo M, Welch WJ. Cyclooxygenase 2 inhibition suppresses tubuloglomerular feedback: roles of thromboxane and nitric oxide. Am J Physiol Renal Physiol 296: F790-F794, 2009.
2. Câmpean V, Theilig F, Paliege A, Breyer B, Bachmann S. Key enzymes for renal prostaglandins synthesis: site-specific expression in rodent kidney (rat, mouse). Am J Physiol Renal Physiol 285: F19-F32, 2003.
3. Cheng HF, Wang JL, Zhang MZ, Miyazaki Y, Ichikawa I, McKanna JA, Harris RC. Angiotensin II attenuates renal cortical cyclooxygenase-2 expression. J Clin Invest 103: 953-961, 1999.
4. Fitzgerald GA. COX-2 and beyond: approaches to prostaglandin inhibition in human disease. Nat Rev Drug Discov 2: 879-890, 2003.
5. Francois H, Athirakul K, Mao L, Rockman H, Coffman TM. Role for thromboxane receptors in angiotensin II-induced hypertension. Hypertension 43: 364-369, 2004.
6. Harris RC, Breyer MD. Physiological regulation of cyclooxygenase-2 in the kidney. Am J Physiol Renal Physiol 281: F1-F11, 2001.
7. Harris R. An update on cyclooxygenase-2 expression and metabolites in the kidney. Curr Opin Nephrol Hypertens 17: 64-69, 2008.
8. Heitzer T, Wenzel U, Hink U, Krollner D, Skatchov M, Stahl RA, MacHarzina R, Brasen JH, Meinertz T, Munzel T. Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C. Kidney Int 55: 252-260, 1999.
9. Kawada N, Solis G, Ivey N, Connors S, Dennehy K, Modlinger P, Hamel R, Kawada J, Emai E, Langenbach R, Welch WJ, Wilcox CS. Cyclooxygenase-1-deficient mice have high sleep-to-wake blood pressure ratios and renal vasoconstriction. Hypertension 45: 1131-1138, 2005.
10. Langenbach R, Morham SG, Tiano HF, Loftin CD, Ghanayem BI, Chulada PC, Mahler JF, Lee CA, Goulding EH, Kluckman KD, Kim HS, Smithies O. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 83: 483-492, 1995.
11. Lin L, Nasjletti A. Role of endothelium-derived prostanoid in angiotensin-induced vasoconstriction. Hypertension 18: 158-164, 1991.
12. Mukherjee D, Nissen SE, Topol EJ. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 286: 954-959, 2001.
13. Nasjletti A. The role of eicosanoids in angiotensin-dependent hypertension. Hypertension 31: 194-200, 1998.
14. phox in the macula densa regulates single nephron GFR during angiotensin II infusion in rats. Am J Physiol Heart Circ Physiol 292: H1685-H1689, 2007.
15. Ploth DW, Mackenzie HS. Tubuloglomerular feedback in one-kidney one-clip hypertensive rats. Kidney Int Suppl 32: S115-S118, 1991.
16. Qi Z, Cai H, Morrow JD, Breyer MD. Differentiation of cyclooxygenase 1- and 2-derived prostanoids in mouse kidney and aorta. Hypertension 48: 323-328, 2006.
17. Qi Z, Hao CM, Langenbach RI, Breyer RM, Redha R, Morrow JD, Breyer MD. Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II. J Clin Invest 110: 61-69, 2002.
18. Schnermann J. Cyclooxygenase-2 and macula densa control of renin secretion. Nephrol Dial Transplant 16: 1735-1738, 2001.
19. Schnermann J, Briggs JP. Effects of angiotensin and other pressor agents on tubuloglomerular feedback responses. Kidney Int 38: S77-S80, 1990.
20. Schnermann J, Briggs JP. Tubuloglomerular feedback: mechanistic insights from gene-manipulated mice. Kidney Int 74: 418-426, 2008.
21. Schnermann J, Weber PC. Reversal of indomethacin-induced inhibition of tubuloglomerular feedback by prostaglandin infusion. Prostaglandins 24: 351-361, 1982.
22. Welch WJ. Effects of isoprostane on tubuloglomerular feedback: roles of TP receptors, NO, and salt intake. Am J Physiol Renal Physiol 288: F757-F762, 2005.
23. Welch WJ, Wilcox CS. Potentiation of tubuloglomerular feedback in the rat by thromboxane mimetic: role of macula densa. J Clin Invest 89: 1857-1865, 1992.
24. Wilcox CS, Welch WJ, Snellen H. Thromboxane mediates renal hemodynamic response to infused angiotensin II. Kidney Int 40: 1090-1097, 1991.
25. Zewde T, Mattson DL. Inhibition of cyclooxygenase-2 in the rat renal medulla leads to sodium-sensitive hypertension. Hypertension 44: 424-428, 2004.
26. Zhang MZ, Yao B, Cheng HF, Wang SW, Inagami T, Harris RC. Renal cortical cyclooxygenase 2 expression is differentially regulated by angiotensin II AT(1) and AT(2) receptors. Proc Natl Acad Sci USA 103: 16045-16050, 2006.